New biopharma firm to accelerate vaccines and protein therapeutics delivery

USA-based Caliber Biotherapeutics has announced the opening of the world's largest plant-made pharmaceutical manufacturing facility in Bryan, Texas, with the capability of producing 10-100 million doses of infectious vaccines per month, and hundreds of thousands of doses of protein biotherapeutics such as monoclonal antibodies.

In addition to its plant-based facility, Caliber will also develop a proprietary product pipeline for cancer and infectious diseases utilizing cell- and microbial-based production systems. The end result, it claims, will be new, more effective and affordable vaccines and biotherapeutics for patients - delivered in a time frame in which they are needed.

Led by physician-scientist and biodefense expert Brett Giroir and Barry Holtz, an internationally recognized pioneer in plant-made pharmaceuticals, Caliber represents a fundamentally different approach to vaccine and drug development.